Integrity of blind trials faces complications in hashtag era

In double-blind clinical trials for pharmaceutical drugs, communication available through social media platforms carries the risk of lifting the veil put in place by researchers.

Holliston's Biostage making $8M stock offering

Holliston organ implant company Biostage is offering roughly $8 million in stock, three months after it was threatened to be removed from the NASDAQ stock exchange.

WPI team finalists in $1M NASA robot challenge

A team of Worcester Polytechnic Institute students, faculty and staff are among 20 finalists in a NASA-sponsored robotics challenge -- the only such team from a university, the space agency announced...

MassEcon adds Devens site to portfolio

MassEcon, a nonprofit organization focused on Massachusetts business development, has added Jackson Innovation and Technology Park to its portfolio of market-ready sites.

Mass. Life Sciences Center offers new startup money

The Massachusetts Life Sciences Center (MLSC) on Tuesday announced a new program that will provide grant funding to early-stage life sciences companies.

Worcester State to dedicate STEM center to $1M donor

Worcester State University will honor an alumnus who donated $1 million to fund STEM research and education.

Having fun identifying your corporate strengths

There are many blocks needed to build a successful business. These blocks are dynamic and contain specific infrastructures and characteristics, but fit together in a cohesive manner.

Marlborough drugmaker completes $2.7M Cambridge purchase

Marlborough drugmaker RXi Pharmaceuticals Corp. has completed its purchase of Cambridge cancer treatment company MirImmune Inc.